OneDigital Investment Advisors LLC decreased its stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 17.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 446,315 shares of the company's stock after selling 93,535 shares during the period. OneDigital Investment Advisors LLC owned 0.37% of Privia Health Group worth $8,725,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of PRVA. First Horizon Advisors Inc. increased its holdings in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock worth $35,000 after acquiring an additional 632 shares during the period. EverSource Wealth Advisors LLC grew its stake in Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock worth $47,000 after buying an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. purchased a new position in Privia Health Group in the 4th quarter worth approximately $51,000. Quadrant Capital Group LLC grew its stake in Privia Health Group by 11.8% in the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock worth $95,000 after buying an additional 511 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its stake in Privia Health Group by 185.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company's stock worth $98,000 after buying an additional 3,249 shares in the last quarter. Institutional investors own 94.48% of the company's stock.
Privia Health Group Stock Performance
Privia Health Group stock traded down $0.29 during mid-day trading on Friday, hitting $23.17. The company's stock had a trading volume of 383,161 shares, compared to its average volume of 775,827. The company has a 50 day moving average of $23.64 and a 200-day moving average of $21.94. The stock has a market cap of $2.81 billion, a PE ratio of 231.72, a P/E/G ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $26.04.
Insider Transactions at Privia Health Group
In related news, CFO David Mountcastle sold 5,630 shares of the company's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the sale, the chief financial officer now directly owns 179,676 shares in the company, valued at $4,021,148.88. This represents a 3.04 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 10.70% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts have commented on the stock. Needham & Company LLC reissued a "buy" rating and issued a $30.00 price target on shares of Privia Health Group in a research note on Thursday, April 10th. Stephens reaffirmed an "overweight" rating and issued a $26.00 price objective on shares of Privia Health Group in a research note on Thursday, January 2nd. Piper Sandler upped their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a research note on Friday, February 28th. JMP Securities set a $29.00 price objective on shares of Privia Health Group in a research note on Friday, February 28th. Finally, Canaccord Genuity Group upped their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $27.14.
Check Out Our Latest Stock Analysis on Privia Health Group
Privia Health Group Company Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Further Reading
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
